Seven new tumor cases reported in Zolgensma patients
Nine patients who have received Novartis' spinal muscular gene therapy Zolgensma have developed tumors following their treatment, the company confirmed Thursday. Seven of those cases were disclosed for the first time. Two may be linked ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.